Roxithromycin, a macrolide antibiotic, is used in the treatment of acne vulgaris, although there have been no reports on its concentration in lesions when administered orally. We investigated the concentration of roxithromycin in acne vulgaris lesions in five patients who received 150 mg roxithromycin orally twice daily for 2 weeks. The mean concentration of roxithromycin in the lesions was 0.54 µg/ml. These results suggest that roxithromycin accumulates at therapeutic levels in the pilosebaceous system.
Introduction
There are three main types of treatment for acne vulgaris (acne): topical or systemic (oral) agents, or physiotherapy. They can be used alone or in combination, depending on the pathophysiology of the condition. 1 As a rule, systemic treatment is used only when topical treatment alone is inadequate or unsuitable. In Japan, antibacterial therapy is mainly used as systemic treatment for Propionibacterium acnes, which is part of the normal flora in the pilosebaceous follicles. Tetracycline antibiotics are the most commonly used agents because they show better accumulation in the pilosebaceous system than other antibacterial agents, i.e. they show good distribution to acne lesions. 2 More recently, treatment of acne with the macrolide antibiotic roxithromycin has been attempted. 3, 4 In March 1999, the use of roxithromycin was approved in Japan for the additional indication of acne associated with inflammation, and it is recognized as a useful agent for the treatment of acne. Therefore we determined the roxithromycin concentration
ROXITHROMYCIN ADMINISTRATION
The patients were instructed to take one 150-mg roxithromycin tablet in the morning and another in the evening every day for 2 weeks. Administration of other antibacterial agents was prohibited, but the use of medications not considered to have an effect on acne was allowed.
MEASUREMENT OF ROXITHROMYCIN CONCENTRATION
The contents of three acne lesions (red papules) from each patient were collected at the end of the 2-week roxithromycin
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administration period by first wiping the acne vulgaris lesion with an alcohol swab, removing the contents of the inflammatory eruption with a comedo expressor, and measuring the drug concentrations using the disk dilution method. 5
PRE-TREATMENT OF SAMPLES
After thorough automated mixing, 0.2 ml of sample was placed in a threaded test tube, 0.05 ml saturated calcium carbonate solution was added, and the mixture was stirred. Then, 0.5 ml distilled water and 5 ml ethyl acetate were added, and the test tube was capped and shaken automatically for 10 min. After centrifugation at 3000 rpm for 20 min, 4 ml of the supernatant (ethyl acetate layer) was placed in a 20-ml test tube. The supernatant was dried under reduced pressure at 40°C in a concentrator, and 20% acetonitrile-phosphate buffer solution 0.1 M (pH 8.0) was added (minimum 0.5 ml) to dissolve the supernatant residue.
PREPARATION OF TEST MEDIUM
The test medium was prepared by dissolving 6 g peptone (Difco, Detroit, MI, USA), 1 g glucose (Kanto, Tokyo, Japan), 3 g yeast extract (Kyokuto, Tokyo, Japan), 1.5 g meat extract (Difco), and 15 g agar (Nissui, Tokyo, Japan) in 1 l sterilized distilled water, with the pH adjusted to 9.
PREPARATION OF TEST STRAIN SUSPENSION
The test strain, Micrococcus luteus ATCC 9341, which had been passaged for two or three generations in trypticase soy agar (BBL, Franklin Lakes, NJ, USA), was cultured in the test medium for 18 h at 35°C. Test strain bacteria were suspended in sufficient sterilized distilled water so that the OD660 = 0.8 (equivalent to a bacterial count of 10 8 -10 9 colony-forming units/ml) and diluted to 1% in the test medium as the inoculum.
After inoculation with the test strain suspension, 7 ml of the test medium was placed in a sterile 90 mm-diameter Petri dish (Nipro, Osaka, Japan). The Petri dishes had been anabolized and dried before use.
PREPARATION OF STANDARD DILUTION SERIES
Standard roxithromycin (Aventis Pharma Ltd, Tokyo, Japan) was dissolved in acetonitrile and a 1280 µg/ml standard stock solution was prepared. This standard solution was diluted with 20% acetonitrilephosphate buffer 0.1 M solution (pH 8.0), and a 12.8 -0.05 µg/ml dilution series was prepared. A calibration curve was drawn from the mean values of three inhibitory circle diameters of the standard solutions and their corresponding concentrations.
SAMPLE ASSESSMENT
Disks 6 mm in diameter (Thin, Toyo, Tokyo, Japan) were used. The disks were impregnated with the standard solution, as a control, or the test sample, placed on filter paper to remove excess liquid, and immediately placed on the inoculated test medium. Each sample was tested three times. The patient samples were treated in the same way, and the concentrations were calculated from the calibration curve.
DIFFUSION AND CULTURE CONDITIONS
After preparatory diffusion for 1 h at room temperature, the samples were cultured for 18 h at 35°C.
Results
Five patients were enrolled in the study (two men and three women aged 20 -25, median 23 years). Figure 1 shows the standard calibration curve for roxithromycin used to measure the concentration in the samples.
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The results show that the mean concentration of roxithromycin in the lesions of the five acne patients was 0.54 µg/ml (0.55 µg/ml, 0.51 µg/ml, 0.72 µg/ml, 0.16 µg/ml and 0.74 µg/ml).
Discussion
The onset of acne occurs in two main stages: the formation of comedones and localized inflammation. 6 Many cases of acne are due to increases in the secretion of sex hormones, especially androgens during puberty. Androgens stimulate the pilosebaceous system and increase lipid biosynthesis. In addition, during the same developmental period, keratin plugs form in the follicular infundibulum, resulting in the accumulation of lipids, bacteria such as P. acnes and others normally present, and keratinized substances in the follicular tubes. This results in the formation of comedones, stage 1 of acne development.
The elevated lipid levels and anaerobic conditions in the comedones provide a suitable environment for P. acnes, and this organism increases in number. Propionibacterium acnes is the most important factor in the inflammatory process of acne. It produces bacterial lipases that hydrolyse the triglycerides in the sebum to form free fatty acids and low molecular weight neutrophil chemotactic factor. Neutrophils that are thus attracted to the hair follicles release active oxygen species. The free fatty acids and active oxygen species cause irritation and weakening of the follicular walls. The contents of the follicles enter the surrounding connective tissue because of the degradation of the follicles and the inflammation progresses from the formation of comedones to redness, papules, pustules, indurations and cysts.
The results of our study in five patients with acne showed that the mean concentration of roxithromycin in the lesions was 0.54 µg/ml, which is considered a therapeutic level. 7, 8 In a Japanese multicentre trial, it was shown that the roxithromycin MIC 50 against P. acnes is 0.05 µg/ml and the MIC 90 0.1 µg/ml. 4 
